Spondyloarthritis (SA) is a chronic inflammatory disease that predominantly affects the spinal column. SA-related pain can be intense, persistent, and disabling. Studies with cannabis have been conducted involving patients with refractory epilepsy, multiple sclerosis, Parkinson's disease, sleep disorders, and chronic pain. Cannabidiol is the major non-psychotropic component of cannabis, has anti-inflammatory and analgesic properties, and exerts anxiolytic and mood-stabilizing effects. This paper reports a case of a 72-year-old male with SA, with mild stenoses of the spinal canal at C4-C5 and C5-C6 and stenoses of the left neural foramina at C3-C4, C4-C5, C5-C6, and C6-C7. The use of cannabidiol in our patient achieved satisfactory results in the control of pain related to cervical spondyloarthritis.

Valdecir Carlos Tadei graduated in Medicine from the Faculty of Medicine of São José do Rio Preto (FAMERP), where he also earned his doctoral degree in Health Sciences. He completed specializations in Anesthesiology, Public Health, Health Management, and Interdisciplinary Pain Assessment and Treatment. He currently serves as an Assistant Professor in the Department of Anesthesiology at FAMERP and practices as a prescribing physician of medicinal cannabis. Dr. Tadei has extensive experience in the fields of Anesthesiology, Pain Management, and Public Health.